This week saw major developments in AI-driven trading and strategic moves by key companies. Recursion Pharmaceuticals (RXRX) surged 15% after the FDA announced plans to replace animal testing with AI-based methods, boosting investor confidence in its drug-discovery platform. In wealth management, Accenture invested in AI-powered tools through GoUpscale, aiming to increase client revenue by 6–8% by personalizing investment strategies.

The US-China tech rivalry intensified as new AI export controls took effect, affecting global supply chains. Analysts warn this could slow quantum computing collaborations in allied countries like India. Meanwhile, IonQ expanded its quantum-AI partnership in Japan, allowing local firms to optimize trading algorithms using its systems.

Environmental concerns hit tech stocks as reports revealed Amazon, Microsoft, and Google used 4.2 billion gallons of water annually for AI data centers in drought-prone regions. Sustainable AI ETFs saw increased trading volume as investors reacted. DXC Technology countered this trend by opening a Canadian AI hub focused on eco-friendly trading solutions.